文献速递产科母胎医学

瞬感血糖监测辅助自我血糖监测对妊娠期糖尿病围产结局的随机对照试验

Flash glucose monitoring addition to self-monitoring of blood glucose and perinatal outcomes in gestational diabetes: a randomized controlled trial.
PubMed 文献 · Am J Obstet Gynecol · 2026-04-02

该单中心、开放标签随机对照试验纳入205例妊娠期糖尿病孕妇,比较瞬感血糖监测联合自我血糖监测与单纯自我血糖监测。联合组达标自我监测血糖比例更低(89.5% vs 92.6%,P=.04),但大于胎龄儿发生率更低(3% vs 11%;P=.05;OR 0.27;95%CI 0.07-0.99)。

要点

  • 辅助瞬感监测未提高低危妊娠期糖尿病孕妇的血糖达标比例
  • 瞬感组大于胎龄儿发生率低于单纯自我监测组,但为次要结局
  • 大于胎龄儿结果需谨慎解读,受样本量与事件数限制

核心结论

  • 在低危妊娠期糖尿病 population 中,辅助瞬感血糖监测未改善血糖结局。
  • 辅助瞬感血糖监测与更少的大于胎龄儿相关,但该次要结局应谨慎解读。

研究设计与样本

  • 开放标签、单中心、随机对照试验,比较瞬感血糖监测联合自我血糖监测与单纯自我血糖监测。
  • 共205例孕妇随机分组(瞬感组102例,单纯自我监测组103例),中位年龄32岁,中位孕前BMI 23.5 kg/m2,中位孕周27周。
  • 预设主要结局为达标范围内自我监测血糖测量的百分比,分析遵循意向性治疗原则。

主要发现

  • 瞬感组达标范围内自我监测血糖测量百分比低于单纯自我监测组(89.5% vs 92.6%,P=.04)。
  • 两组中位空腹及餐后1小时自我监测血糖浓度相当,且均在推荐目标范围内。
  • 瞬感组大于胎龄儿发生率低于单纯自我监测组(3% vs 11%;P=.05;OR 0.27;95%CI 0.07-0.99)。

临床怎么用

  • 对低危妊娠期糖尿病孕妇,辅助瞬感血糖监测不应以改善血糖达标为主要目的常规使用。
  • 瞬感监测可能与大龄儿减少相关,但现有证据不足以据此改变常规监测策略。

局限性

  • 样本量有限且事件数少,大于胎龄儿为次要结局,需谨慎解读。
  • 单中心、开放标签设计可能引入偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Self-monitoring of blood glucose represents the standard for glycemic monitoring in gestational diabetes mellitus, while the role of continuous glucose monitoring remains uncertain. OBJECTIVE: To assess whether adjunctive flash glucose monitoring improves achievement of established self-monitored glucose targets compared with self-monitoring alone and to examine maternal and neonatal outcomes. STUDY DESIGN: We conducted an open-label, single-center, randomized controlled trial comparing adjunctive flash glucose monitoring plus self-monitoring of blood glucose with self-monitoring of blood glucose alone. The prespecified primary outcome was the percentage of self-monitored glucose measurements within the established target range. Secondary outcomes included maternal and neonatal outcomes. Analyses followed the intention-to-treat principle. RESULTS: A total of 205 women (median age, 32 years; median prepregnancy body mass index, 23.5 kg/m2; median gestational age, 27 weeks) were randomized (102 to adjunctive flash glucose monitoring and 103 to self-monitoring alone). The percentage of self-monitored glucose measurements within target range was lower in the adjunctive flash monitoring group (89.5% vs 92.6%, P=.04). Median fasting and 1-hour postprandial self-monitored glucose concentrations were comparable between groups and within recommended targets. The incidence of large-for-gestational-age infants was lower in the flash monitoring group (3% vs 11%; P=.05; odds ratio, 0.27; 95% confidence interval, 0.07-0.99). CONCLUSION: Adjunctive flash glucose monitoring did not improve glycemic outcome in this low-risk gestational diabetes population. However, it was associated with fewer large-for-gestational-age neonates, a secondary outcome that should be interpreted cautiously given the sample size and number of events.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Zorko K, Munda A, Janež A, et al. Flash glucose monitoring addition to self-monitoring of blood glucose and perinatal outcomes in gestational diabetes: a randomized controlled trial. Am J Obstet Gynecol. 2026. PMID: 41935728. doi:10.1016/j.ajog.2026.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。